West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...
MedPage Today4h
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
FDA approves first rapid-acting insulin
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Sanofi gets FDA approval for NovoLog insulin biosimilar
Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...
Does Medicare Cover Ozempic?
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
drugdeliverybusiness9h
Medtronic warns on air pressure issue with certain MiniMed insulin pumps in Europe
The MiniMed 780G with the Guardian 4 sensor. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) issued an urgent field safety ...
pharmaphorum2d
Novo Nordisk launches first smart insulin pens for NHS patients
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.